full comment requir non-u analyst conflict disclosur
pleas click link
opportun leadership upgrad outperform
upgrad sector perform
attract risk/reward post adcom pull-back rais price target
lower europ food bev can/signod strong
impress orr maintain melanoma best increas target
 best breed
gain share first time long time
ep solid result outlook suggest moder remain strong
full data esmo detail sever patient popul unmet need
unexpectedli depart compani ultim unfaz sulopenem timelin
eltanexor data esmo show unexpect pipelin flexibl solid tumor
full garnet data esmo see orr larg line abstract
chillin discount outperform
preview on-going transit smaller better celestica
third quarter earn preview cheat sheet
earn preview outlook commod deck updat
third quarter earn preview cheat sheet
interpubl group compani
price prior day market close estimate unless otherwis note
updat loan flat week
third quarter earn preview cheat sheet
expect posit trend continu preview
visa europ still focu macro condit stabl preview
think impact china game crackdown
model updat capit market transact disposit
keep nose grindston push higher earn
adjust estim reflect lower cap rate
ceo lucier step buy dip
still cautiou lower estim maintain sp
model updat updat estim disposit hurrican florenc
knight round tabl
march promis higher profit
adjust number ahead
earli takeaway astro meet
search clariti earn kick
week octob
weekli perspect healthcar industri compani news valuat updat
continu digest learn last week
top investor question week payment processor servic
earn week ew
rise rate environ
news nashvil
investor day await news
specialti pharma
focus week
feedback pti doublet
find research
insight www rbcinsightresearch com global research destin web contact capit market sale
repres access global research site use ipad app research
event gx advair symphoni updat india gx week
valu usd unless otherwis note
opportun leadership upgrad outperform
result report like lacklust model
ramp compstore growth result slightli
higher compstore growth increas ep estimatesimpli compound-annual-growth-rate
mid-teen ep growth thereaft survey work demonstr
signific upsid menu digital/deliveri opportunitiesand believ
manag team increasingli execut believ
recent pullback creat accept entri point ep
upgrad chipotl outperform sector perform new
target equat ep
look result identifi potenti sale win
retreat recent high believ chipotl share offer compel risk/
reward head look earn
believ downsid risk given food safeti incid ohio
rbce compstore con said believ favor stock set-
given menu innov digit initi focu improv
less downsid risk food safeti upsid risk market win
note present data two survey media-ment analysi
leav us convinc upsid scenario defin
hsd compstore growth driven digit usag menu news downsid
scenario character sale setback on-going food safeti
headlin chipotl qualiti ingredi rank eight fast casual
chain show on-going need heal
larg cap growth pm go discuss valuat macro cycl
rariti growth invest chipotl risk includ
rel recent histori poor servic score food safeti exposur
labor avocado inflat premium valuat said chipotl
outsiz growth potenti versu sector popul exposur
lacklust us fast food compstore growth currenc slow em demand
believ chipotl repres rare non-tech opportun hyper-growth
upgrad sector perform
combin strong sale earli sign oper leverag
share price under-perform vs european consum stapl sector
last four month prompt us upgrad rate sector perform
under-perform back increas price target
main gripe downgrad rate under-perform june link
note pernod ricard unabl unwil convert enviabl
revenu perform correspondingli robust margin growth there
remark absenc oper gear manag
caution impact higher raw materi cost expens eaux
valu eur unless otherwis note
valu usd unless otherwis note
de purchas year ago readi use steep increas
price agav
even allow though think guidanc growth profit
recur oper conserv current exchang
rate estim transact currenc benefit
year updat forecast assum organ exclud
currenc benefit margin growth roughli basi point
turn drive forecast increas rel high histor
standard outrag view busi forecast
deliv organ revenu growth back
share de-rat oper leverag though still modest
appar start becom evid sale growth strong accordingli
upgrad rate sector perform
attract risk/reward post adcom pull-back rais price target
share pull back high follow posit oct
advisori committe adcom meet dsuvia meet brought posit
vote favor benefit outweigh risk set expect
approv pdufa leav attract set-up
rais target reiter op-spec risk rate
like set-up upcom pdufa revisit stock ahead
anticip approv vote ask whether benefit dsuvia
propos rem outweigh risk use adult patient medic
supervis set posit also thought fda appear support
brief doc link meet fda divis director dr hertz also indic
compani submit kind inform ask
respons question committe around whether
address concern rais initi review collect meaning
improv set-up head upcom pdufa pull-back
follow post adcom high stock halt meet
leav attract set-up stock view
lower europ food bev can/signod strong
execut well signod global bevcan vol europ
food drag dec investor day could posit catalyst
investor gain greater understand signod also find price
opportun us bevcan posit ebitda yield look
attract
crown ebitda slightli ahead our/street
lower expect america beverag europ food challeng
weather poor harvest yield off-set stronger apac signod
valu usd unless otherwis note
valu usd unless otherwis note
reduc estimates/target slightli lower europ food outlook
bevcan remain robust reduc eps/ebitda
tough comp america beverag weaker europ
beverag mideast weak spain invest importantli less cost
absorpt europ food compani work food inventori built
hope higher volum better harvest eps/ebitda
come lower base
target lower ebitda also reiterate
adjust target lower work
capit help off-set slightli lower ebitda outlook
readthrough could show similar strong global bevcan growth
also think price opportun bevcan quit attract given
expect us volum renegoti
annual seem confid ration industri behavior price
maintain outperform bevcan volum remain strong de-lever
intact get year-end delev turn year think
cck dec investor day cincinnati could posit catalyst
compani discuss signod greater length
impress orr maintain melanoma best increas
weekend late break poster present esmo present data
addit melanoma patient treat previous
effect dose updat orr previou cut
upper end rang thought would support
true activ new safeti signal emerg abscop respons continu
benefit seen posit neg patient overal believ
essenti best-cas scenario data cut help reduc
uncertainti around contribut activ open-label checkpoint
combo stem invers dose-respons well set compani
well potenti ph iii collabor pivot success littl bake
share valu view see meaning upsid potenti
result increas price target reflect increas
po opportun program reiter outperform
weekend late break poster present esmo present
data addit melanoma patient treat
previous effect dose
twelv new patient respond maintain
overal orr report patient
progress free surviv like primari endpoint registr trial
extens pembro alon support high po melanoma program
littl bake share valu view see meaning
upsid potenti result increas price target
reflect increas po opportun program
valu usd unless otherwis note
valu usd unless otherwis note
sector perform-r honeywel post high-qual market
fixat move part compani face especi
challeng offset tariff root strand cost spin
would downplay worri new sec asbesto account investig
risk/reward look balanc catalyst behind
support neutral view
expect healthi organ sale growth increment
convers howev move part compani guidanc bridg
overshadow feel-good beat rais particular
challeng root strand cost offset tariff headwind look
biggest challeng regard disclosur new sec investig
honeywel asbesto account understand honeywel
recent appli new conserv assumpt legaci bendix
asbesto liabil expect sec investig event
lower price target
compani core fee busi came weak outlook leav
investor clear visibl given revenu pressur lack
confid number lower earn price target
earn summari state street report ep rel
line estim consensu estim
prior quarter year-ago quarter third quarter
perform rel estim driven stronger net interest incom
lower non-interest expens lower effect tax rate versu
estim partial off-set lower fee revenu lower effect tax rate
rel estim ad ep
servic revenu pressur sentiment earn call
posit compani guid servic revenu
flat exclud charl river develop contribut
alreadi came expect expens expect slightli
level combin two factor pressur earn
estim cloud outlook
ep estim price target lower ep estim
respect estim reflect
charl river acquisit assum interest rate increas remaind
increas lower price target reflect
pressur servic fee
core beat estim perform solid via core growth paypal
loan ad expect credit remain favor loan growth/oper
valu usd unless otherwis note
valu usd unless otherwis note
leverage/shar buyback support healthi ep upsid view share
attract valu
beat higher nii lower provis ep report well
estim consensu wide rang given paypal better
model nii rsa lower model provision/loss primari
posit paypal deal complet ad nois perform quarter
nii higher paypal credit acquisition/cor growth net interest incom
increas substanti qtr/qtr vs via paypal nim
vs total loan increas qtr/qtr
year/year healthi core growth ad paypal loan rsa
percentag averag receiv increas vs
expens moder higher growth/payp contribut expens
higher vs estim
 higher model paypal onboard effici ratio nonetheless
remain flat sequenti
charge-off improv modestli reserv build qtr net charge-off
came loan well estim loan
loss provis moder estimate/consensu roughli
 reserv build paypal core quarter
credit remain favor solid perform contribut lower provis
updat estim rais core ep
stay unchang initi estim continu reflect
outlook core loan growth manag charge-offs/oper
interpubl group compani inc nyse
 best breed
put anoth strong growth quarter outlook remain rosi
estim includ acxiom continu expect good growth margin
expans rais think deserv premium peer
organ revenu punchi well ahead street
includ us accel appear track meet exceed organ
growth guidanc qualit commentari also posit
manag call improv tone cpg growth spend
top client tailwind new busi
acquisit close octob adjust model
acxiom base upon organ growth ebita margin go
forward refer ebita/margin adj ep excl deal-rel intang
amort new ebita adj ep directli compar prior
think outlook justifi upper end rang new target
adj ep prior combin healthi
yield continu rate outperform best-of-bre ad agenc
see appeal valu incom skew investor
valu usd unless otherwis note
valu usd unless otherwis note
gain share first time long time
behind impress organ growth record bp weight share
gain quarter first time seven year compani
gain quarterli share year-over-year question pg busi improv
think current valuat alreadi emb recoveri long-run top-lin
organ growth standout organ growth impress high
qualiti driven improv us china largest market
also biggest area investor concern manag comfort
retail accept price increas visibl
competit action year past pg price action led share eros
approach current situat caution
monitor groom babi groom busi acceler
year averag basi second straight quarteran encourag sign given
continu competit pressur shelf space categori soft
babi feminin famili busi remain weakest
deceler averag basi price also neg despit
compani price announc concern
adjust estim price target forecast organ growth
vs previous guidanc howev maintain ep
estim vs reiter guidanc given worsen fx
commod pressur result chang dcf-base price target
repres downsid current level
lower price target account svu oper
miss wors expect financ term guid low-doubl digit deal
accret appear low doubl digit dilut
lower price target due lower expect
contribut post deal close ebit higher interest
expens due tougher debt financ term increment interest
origin estim think svu deal dilut
year one definit vs ldd guid definit
includ svu retail dcf-deriv impli
ep solid result outlook suggest moder remain
western allianc produc anoth strong quarter good loan deposit
growth core margin dynam help gener posit oper
leverag manag took modestli cautiou tone growth
valu usd unless otherwis note
valu usd unless otherwis note
margin still appreci compani abil produc
peer growth return impress return strong credit qualiti
report ep ahead consensu report result
includ non-recurring item essenti offset core basi
view result strong driven solid revenu growth trend
fundament gener strong loan increas sequenti
billion deposit increas sequenti billion report
margin increas bp sequenti estim core margin
ex-accret rose bp drove increas net interest
incom million oper expens increas million
driven elev charit contribut expens though core effici
ratio still improv compani gener impress
roa rotc
outlook manag increment cautiou loan growth trend
given heighten competit though longer term growth outlook
remain favor recent secur reposit action drive near term
margin expans outlook expect show stabil due
continu rise fund cost competit manag also adjust
revenue-to-expens target maintain around
oper effici pace next sever quarter total outlook still
suggest doubl digit earn growth favor
estim updat adjust ep
maintain ep lower price target
reflect recent chang peer multipl
full data esmo detail sever patient popul unmet need
attend present data rucaparib
biomark metastat castrat resist prostat cancer mcrpc esmo
well investor event weekend follow friday abstract
contain preliminari data see note full
present see sever key point suggest even impress
profil indic friday abstract rucaparib see unconfirm
orr brcamut pt reach present like possibl
confirm orr meet preview best-cas scenario
see preview surpris friday sell-off follow
initi pre-market posit reaction investor feedback suggest
sell-off larg due concern print competit prostat
cancer headlin risk azn trial lynparza ovarian cancer
mainten present weekend continu view prostat
cancer data potenti util blood/plasma base biomark
companion diagnost differenti support acceler path
market given to-dat robust data seen parpi
class indic howev anticip may need demonstr
commerci traction ovarian cancer in-lin print and/or potenti
acceler file even earlier guid ie farther ahead
potenti competit order investor grow posit stori
valu usd unless otherwis note
valu usd unless otherwis note
weekend esmo present updat data forward ii
combo drove confirm orr all-com
medium high fr expressor respons rate declin
somewhat vs initi preliminari orr report popul
sgo see note data appear show benefit
beyond could expect alon popul
see combinatori additive/synergist efficaci somewhat less clear vs
mirvetuximab monotherapi fr high express patient await
matur pfs/dor data better assess dynam
poster esmo tap mondayon early-stag program
prostat cancerw note sever increment updat inovio
highlight compani variou effort track pivot program
cervic dysplasia data expect
await combo readout io program
step-wis develop platform valid around compani
broader effort believ offer hint encourag
overal approach especi catalyst value-cr potenti
still distanc next coupl year reiter outperform
updat data ph open-label studi biochem recurr
prostat cancer patient continu well-receiv friday abstract
note continu evid safe well-toler immunogen dna-
vaccineand on-going evid clinic efficaci fall outsid
valuat given earli stage competit combo-ori space
believ manag intent find right partner opportun
program increment continu progress increasingli
compani recent announc public preclin data cancer
research highlight potenti dmab platform expand target
cancer updat across platform
valu usd unless otherwis note
unexpectedli depart compani ultim unfaz sulopenem
friday market close itrm announc immedi departur
jeff schaffnit opportun speak manag
addit context news understand surpris believ
key clinic program timelin reiter core leadership intact
compani posit absorb disrupt albeit minim view
move ahead reiter outperform specul risk rate
manag reiter core team well equip advanc
program continu build commerci valu proposit
importantli pivot timelin intact recent start program
valu usd unless otherwis note
valu usd unless otherwis note
trackdata sulopenem three program eye follow
recal sulopenem earli inning ph iii program itrm
build fairli robust commerci strategi continu
effort architect way well mr schaffnit
month tenur compani acknowledg remain open commerci
partnership asset view consist previou posturebut still
noteworthi mention current model ww sale potenti
sulopenem across indic set po
eltanexor data esmo show unexpect pipelin flexibl solid
esmo weekend present late-break abstract eltanexor
treatment metastat colorect cancer mcrc indic
eltanexor demonstr efficaci compar late-lin therapi
mcrc
importantli eltanexor also appear
improv upon sever
hematologic/gi typic observ selinexor provid valid
rational drug use broader rang hematological/solid tumor
indic md prostat cancer toler bar overlap
requir optim profil
close friday regn/sni announc fda approv dupix
dupi patient age year older moderate-to-sever asthma
eosinophil phenotyp oral corticosteroid depend label
come slightli narrow vs best case scenario dupi indic
patient irrespect eosinophil count though non-eosinophil restrict
label patient depend corticosteroid grant differenti
patient popul see potenti dupi label restrict use
high eosinophil patient given lack appar treatment benefit seen low
eosinophil patient dupi program recal patient eosinophil
count cells/microlit differ sever exacerb
rate dupix versu placebo though dupix achiev stat-sig benefit
overal trial popul
full garnet data esmo see orr larg line abstract
esmo weekend tsro present updat data msi-high
msi-h cohort tsro registration-en garnet trial
endometri cancer data includ present esmo detail
confirm orr patient least one post-baselin tumor
assess confirm respons data larg in-lin
orr report friday epost discuss abstract esmo
valu usd unless otherwis note
valu usd unless otherwis note
initi releas see note unconfirm pr data remain slight
improv result present earlier year see note
show orr pr confirm
unconfirm updat result present esmo garnet rise
includ singl unconfirm partial respons respons
remain on-going median durat treatment
met despit promis result continu anticip
competit headwind launch behind entrench keytruda
chillin discount outperform
anticip solid sale quarter chili result reintroduc
menu ep upsid fiscal end septemb like limit
food margin headwind believ price action menu move
help margin upcom quarter believ brinker current
valuat discount yield ntm price-to-earnings vs casual dine peer
reflect deep investor skeptic chili deliv profit growth
near-to-medium term maintain outperform rate
rais compstore ep estim rais chili compstore
estim prev con expect sale traffic trend
improv quarter also rais ep estim
con guidanc sale improv versu
initi expect begin quarter growth come expens
traffic believ top prioriti brinker establish traffic
growth around new menu news consist everyday valu
like four factor drove out-performance versu casual dine industri
chili back-to-bas strategi focus core menu item servic
digit off-premis growth return compel everyday valu
platform rel strong industri growth
lap comparison
valuat allow favor set-up earn given brinker
ntm price-to-earnings yield believ investor hearten
brinker improv compstore traffic growth despit like weaker expect
restaur level margin view next quarter pivot brinker
skeptic turnaround attribut improv strictli easi
comparison brinker abl deliv within guidanc compstore
growth roughli flat restaur margin exclud sale-lease-back transact
revenu recognit chang believ could signific potenti
re-rat stock
valu usd unless otherwis note
valu usd unless otherwis note
preview on-going transit smaller better celestica
addit commentari celestica pend acquisit impakt updat
celestica portfolio review like overshadow result guidanc
octob celestica re-affirmed guidanc outlook call ep
line street guidanc expect guidanc slightli
street given double-digit growth celestica at segment maintain sector
expect ep line street guidanc celestica report
result octob manag re-affirmed guidanc
revenu adj ep octob estim street
line celestica guidanc specif outlook call revenu
y/i estimate organ near street expect adj oper
margin increas expect adj ep y/i
line street
mid-point guidanc may slightli exceed street expect strong
at growth report contract termin like commenc
believ celestica revenu guidanc may exceed street
expect addit margin may rise street estim
continu mix shift at result believ celestica may guid
revenu y/i estimate organ adj ep
mid-point slightli street
addit commentari impakt portfolio review possibl octob
celestica updat medium-term oper margin outlook
light report contract termin believ
manag may provid addit commentari expect contract
revenu result on-going program review larg
contract termin possibl tariff-rel disrupt may increment
headwind revenu celestica may also provid addit
disclosur relat expect accret impakt acquisit
expect report line ep estim slightli
street revenu street though fx acquisit
could creat nois quarter addit note trim
revenu expect chang ep estim
questions/concern addit result look
updat gpn continu shift toward integr solut impact
recent announc acquisit fx competit
dynam perform us direct iso uk busi
reduc revenu expect given greater fx headwind
origin forecast especi canada asia compani us
wholesal iso busi declin double-digit coupl fewer
process day reduc revenu estim
respect
addit take revenu estim flow
fx headwind result revenu
valu usd unless otherwis note
valu usd unless otherwis note
third quarter earn preview cheat sheet
report earn come sever lumpi quarter
vs expect remain show stori includ
execut lower estim stabil competit perspect
respons correct action announc last quarter investor like
look return consist maintain sector perform rate
target await better execut stabil result
need know report result
consensu revenue/ep expect roughli in-lin vs
guid midpoint also look
margin vs guidanc consensu adjust ebitda
ebitda margin vs guidanc consensu
sinc report share
vs ytd share vs investor
interest quarter mute normal larg center
around competit landscap trend stabil core
collabor market employe retent moral follow sever quarter
lumpi result financi perform vs lower estim evid
estim bottom like take time regain investor
confid also realiz could take sever quarter show improv
consist core collabor think model grow
compound-annual-growth-rate gener strong adjust ebitda/fcf maintain sector perform
view expect reason continu see upsid
combin azur server product kpi made model tweak reflect
pc suppli chain issu continu like share given growth vs valuat
reiter price target
estim rev/non-gaap ep vs consensu
view expect reason key kpi model azur growth
y/i commerci growth y/i server product growth y/i
model adjust updat thought pc demand
reflect current suppli chain issu meaning lower-
end devic model also updat includ linkedin commerci
revenu commerci cloud revenu gross margin kpi
made minor model adjust revenue/ep move
revenue/ep
continu like share given growth double-digit revenue/low- mid-
teen ep versu valuat reiter price target
forecast sequenti declin coverag univers go
earn season ebitda estim higher consensu
compani coverag univers materi
lower lumberco wft cfp ifp cff osb name osb also
timber reit wy page estim chang
cdn cfp ca cff
cwx ifp kpt
osb wef wft
us ip
merc
rfp
wy
us
canada norbord west fraser canfor interfor cascad
third quarter earn preview cheat sheet
report earn overal expect solid result
outsid quarter think investor focu bill initi
guid seem somewhat de-risk follow estim cut mid-
septemb maintain outperform rate target
need know report result overal
expect solid quarter due solid market demand sever long-term
driver remain sinc result share vs
 ytd share vs sentiment
moder sinc last quarter investor concern guidanc
previous address competit moder growth lack
signific upsid result bill outlook
think upsid bill like could point reiter bill
guidanc slightli lower guid pass upsid
lower bill expect slightli
take pressur outlook check continu pick
convers addit resourc better leverag sale
channel success beyond core protect advanc threat investor look
emerg next tap-lik opportun think could come
efd threat respons overal think revenu expect
larg de-risk actual rais ep estim slightli
believ upsid could exist vs compani initi guid offer call
also believ upsid revenu dollar exist compani move
next two year maintain outperform target
report earn overal expect anoth solid quarter
in-lin constant currenc guidanc realiz fx could bp headwind
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
growth continu like lt opportun growth margin
improv transit recur revenu acceler multipl
catalyst maintain outperform target
need know report result would
look year momentum continu though expect moder
somewhat sinc last quarter stock sinc result vs
ytd share vs opportun market
compani quarter investor focus iot gain scale
ramp rockwel partnership alreadi close deal core-cad strength
pend subscript mainten price increas new team focus
convert azur partnership mani could
potenti sourc upsid think topic like remain focu along
end perpetu licens sale global januari could
pull deal believ guidanc provid
consensu estim remain due
lack comparison start estim move
guidanc believ book could point constant currenc
growth in-lin rbc/consensu expect look
vs consensu also slightli adjust
ep estim base sole better align long-term tax rate assumpt
present analyst day vs estim previous
third quarter earn preview cheat sheet
report earn overal expect solid quarter
follow-through strong result compani remain favorit
us given best-in-class unit econom above-averag growth lack competit
expand use case leverag maintain top pick pt
need know report result overal
would look follow-through last quarter strong result upsid
subscript bill growth last qtr would note believ
quarter got good start strong pipelin larg deal highlight
robust us feder quarter addit check lead us
believ strong momentum emerg product csm hr
secop intellig account net-new acv last quarter
itsm net-new acv also strong part top deal check
gsi partner posit throughout quarter expect
moder recent tech draw sinc last
quarter vs ytd stock vs
solid quarter expect larg in-lin guidanc
keep expect check look next year anticip launch
new product autom task cfo financ depart
could repres nice catalyst remain top pick one wed
focu tech multipl continu compress
expect posit trend continu preview
believ tss report line high-end estim vs street
estim vs street though note total
revenu denomin canadian dollar gener uk/
europ note also adjust ebitda estim reflect
valu usd unless otherwis note
merchant solut expect y/i growth revenu
oper profit margin segment note
merchant solut enter year face headwind
believ investor look organ growth integr
direct busi remain similar level around
see anyth current question expect
consum solut much like previou quarter would surpris
consum solut segment continu year-to-d out-performance
rel expect increas adopt dda new
solut forecast revenu growth oper
profit margin consum solut segment howev
like previou quarter loss turbotax act headwind
guidanc would expect tss manag either keep guidanc
flow upsid believ investor interest
outlook though anticip offici guidanc
last quarter manag increas net revenu guidanc mid-
point ep guidanc call net revenu
adjust ep
visa europ still focu macro condit stabl preview
expect visa post result line eps/net revenu
estim street ep aggreg volum trend includ fx
volatil appear remain sequenti stabl compani
continu benefit re-pric opportun europ
valu usd unless otherwis note
thought quarter term quarterli result believ
investor look updat visa europ integr synergi
manag recent commentari run ahead
plan price opportun addit area interest could includ fx
shift headwind tailwind earlier year interchang
settlement growth visa direct oper leverag expens growth
competit acquisit aimia aeroplan loyalti program
outlook greatest interest investor opinion
guidanc note like face headwind fx
chang revenu recognit top-line accord recent
manag commentari increas effect tax
rate current forecast revenu increas y/i
street ep increas street
think impact china game crackdown
valu usd unless otherwis note
need know chines regul crackdown video game pick
last coupl quarter author delay game approv
monet crackdown howev think expos
us mobil game market rel china instanc io sale
popular game fortnit come us accord sensortow
addit new iphon xs/xs-max increas share game
market continu growth non-china mobil game market includ
us provid partial off-set china headwind estim
app store quarterli china game revenu million slowdown
growth rel small number materi
revenu cadenc servic segment final given china video game
relat headwind start appear march think guid would
account extent net/net maintain outperform rate
model updat capit market transact disposit
updat estim debt refinanc disposit share repurchas
updat estim debt refinanc disposit share repurchas
think headwind relat china video game industri would
meaning impact result
valu usd unless otherwis note
keep nose grindston push higher earn
although revenu perform trail expect deliv
gener steadi quarter control expens declin credit cost
made fairli consist progress improv expens profil
whittl away excess capit dividend share repurchas tuck-in
valu usd unless otherwis note
valu usd unless otherwis note
report ep includ million pre-tax charg
relat acquisit franklin american mortgag exclud item
core ep estim consensu
prior quarter year-ago quarter
increas core ep estim
respect estim incorpor perform
recent consumm acquisit addit assum one
interest rate hike well rate hike
develop pemigatinib treatment transloc
cholangiocarcinoma sunday present updat data highlight
increas orr median month median os month
new safeti signal emerg result shed light
promis pipelin littl believ bake current
level continu view share compel valu
new data show increas orr cholangiocarcinoma patient
treat pemigatinib provid evid efficaci
pemigatinib profil appear favor comparison gemcitabin
cisplatin target potenti ph iii studi
continu believ under-valued trade near floor level
continu posit pipelin result drive share upsid go forward
adjust estim reflect lower cap rate
remain encourag regard compani progress reposit
portfolio believ manag quickli redeploy proce
next sever quarter howev due higher privat market valuat
reduc estim reflect lower acquisit cap rate similarli
modestli increas in-plac estim driven reduc assum cap
rate bp
valu usd unless otherwis note
valu usd unless otherwis note
announc complet billion disposit includ
primoni jv north cypress deal ernest sale expect compani
complet redeploy proce new invest
abl take advantag favor market price given
still expect compani complet million acquisit
billion billion howev significantli reduc
acquisit cap rate assumpt
compani still plan reduc steward concentr mostli
done futur invest
reduc report ffo estim
share
share lower earn outlook due time recent disposit
combin lower acquisit yield
ceo lucier step buy dip
believ weak share friday overdon
would buyer dip view ceo chang posit
sharehold concern compani result given
recent check nass
ceo greg lucier step chri barri step matt link promot
presid announc friday chri barri becom
compani ceo effect novemb also serv nuva board mr
barri join presid surgic innov
speak compani think mr lucier step
feel compani solid foot global self-
manufactur track
share sell lack guidanc updat confid
quarter fine spoke nuva cfo advis read
lack guidanc updat manag updat guidanc octob
compani report result think manag feel
need updat guidanc given compani report day
also believ nuva quarter fine due dilig come
nass point stabl improv spine market
mr barri solid robot background prove benefici
oversaw mdt surgic robot initi program
gener manag reort believ robot experi may
prove import given behind peer robot
develop spine space expect robot arm ad
compani puls platform nass
valu usd unless otherwis note
increas estim stronger forecast conway-to-mont
belvieu price differenti stronger north dakota product also
incorpor recent announc growth project continu view
core hold one prefer way invest midstream reiter
outperform rate maintain price target
conway mont belvieu price differenti boost earn conway
mont belvieu price differenti averag vs previou
estim
announc growth project project includ west texa
expans ga process ngl pipelin expans fraction
gener ebitda return collect increment
ebitda ramp
north dakota product hit record level august crude oil natur
ga product mboe/d sequenti oil product
increas mb/d mb/d
still cautiou lower estim maintain sp
weak one highest margin multipl busi refinish
concern slow china/auto oem price cost reduct sharehold
return effort help mitig downsid risk said broader concern
potenti slowdown indic tariff neg impact china
consum sentiment fair valuat stay sidelin
valu usd unless otherwis note
report ep our/street segment ebit
lower perform off-set higher industri
recal pre-announc neg last week raw logist softer china/
auto oem weaker refinish fx
read-through like see raw materi pressur
new raw comp eas price initi esp paint
store help off-set alreadi saw custom destock issu
refinish last year envis larg headwind said
expos fx headwind potenti slow china oem
maintain sector perform expect margin compar
within bp y/i remain cautiou china auto oem
biggest swing factor could depend
govern enact consum incent took build
cushion case custom destock refinish raw/logist headwind
continu longer expect come lower base
appli multipl ebitda result target
unchang overal remain cautiou solid perform
market aero na off-set weak elsewher
refinish auto oem europ compani capit deploy
alreadi reflect estim ebitda await better
entri point get construct
model updat updat estim disposit hurrican florenc
valu usd unless otherwis note
valu usd unless otherwis note
updat model asset sale impact hurrican florenc
knight round tabl
larg cap energi investor use core hold reward
stock outperform oih past year stock
under-perform ytd investor becom frustrat neg ep revis
recent stock action may turn point
larg cap energi investor use core hold
reward stock outperform oih past year stock
under-perform ytd investor becom frustrat neg ep
revis stock action today may turn point
chang ep estim howev think street ep
settl rang essenti in-lin lead edg revis
mean street ep like revis lower
march promis higher profit
sti well posit benefit faster-grow southeastern economi
potenti faster revenu growth continu laser-lik focu expens
commit return larg amount excess capit set tabl
posit outlook stock
sti report ep estim adjust
one-tim item calcul core ep ep beat estim
decreas increas rel
valu usd unless otherwis note
valu usd unless otherwis note
estim perform driven lower credit loss provis control
expens in-lin core non-interest incom partial off-set modestli lower
increas ep estim
respect estim reflect one addit rate hike
increas
adjust number ahead
ore price remain resili much resili analysi
would suggest well good quarter increas forecast
fall chines steel profit continu approach vale share caution
current level
increas forecast follow product number larg
back mark market iron ore price relat impact provision
price adjust better sale
although remain bloomberg consensu ebitda quarter
higher ship cost potenti higher cost rise inflat brazil
could caus result underwhelm
written fall fundament steel demand
therefor fall steel profit like weigh iron ore market
period elev grade penalti spread view despit
multipl structur posit upcom catalyst rbce
ebitda exposur iron ore continu see appreci better entri point
vale
howev statist around steel iron ore china continu confound
profit steel produc fallen nearli half last
month would expect level steel product continu would
expect inventori start build seen
evid yet
reiterate under-perform rate price result
expect market octob
earli takeaway astro meet
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
strong slate new/upcom product launch astro includ
flash therapi
describ vision adapt therapi ai-driven adapt
treatment solut offer halcyon initi may expand
platform later autom multi-mod mr/ct/pet imag
fusion perform point treatment believ
adapt therapi solut could approv halcyon next year astro
believ halcyon sever featur make attract
rel first gener halcyon addit kv imag one
main differ halcyon first gener halcyon
addit iter cbct imag ad halcyon better
bravo var new brachytherapi afterload key featur built-in
safeti check better workflow/effici bravo nice addit var
launch probeam smaller footprint previou
system probeam single-room proton therapi system smaller
footprint previou system reduc construct cost
new system rotat gantri iter cone-beam ct imag
high-definit pencil-beam scan technolog
preclin work ultra-high dose rate treatment flash therapi
defin flash therapi ultra-high dose rate extern beam therapi
deliv second hypofraction form preclin work suggest
flash result reduc normal tissu toxic enhanc immun system
respons believ flash still sever year away full commerci
neg sentiment weigh global supplier group solid growth
auto product y/i north america expect move
lower europ despit lower volum specif oper factor
canadian supplier support higher earn tariff trade
concern continu weigh multipl quarter even
nafta effect replac usmca
item watch result
magna revenu earn growth led strength north
america steyr expect revenu y/i larg due
strength north american product cpv steyr off-set declin
eu volum expect updat guidanc reflect
divestitur fp busi current steyr program well
chang growth outlook europ asia
linamar grow content powertrain macdon drive growth
industri segment revenu forecast project y/i increas
ebitda y/i see y/i revenu growth powertrain
segment expect industri segment y/i
anoth full quarter contribut macdon
martinrea expect anoth quarter margin improv forecast
revenu decreas y/i lower-margin busi roll lead
higher ebitda y/i ebit margin y/i
look detail new busi launch on-going margin
believ year acquir svu origin guid ldd accret
ep becom slight dilut debt financ term deal worsen
svu core busi perform track origin estim
svu wholesal busi ebit estim give
credit seeing/know svu margin troubl estim svu wholesal
run behind expect fy ebit estim svu ex retail
ebit contribut year deal close ex one-tim item
relat integr origin anticip
increment interest expens howev tougher financ term
final estim increment interest expens
would actual base chang estim year
dilut ex svu retail includ svu retail
dcf-deriv price target svu impli ev/pf year-
one ebitda incl svu retail reiter sector perform larger risk
search clariti earn kick
last week took detail look price/cost environ
build product potenti near-term storm impact local market
afford dynam hous market part report
also lower estim across coverag expect
compani report week greater detail found
sector note build product still navig stormi water lower
estim homebuild local market afford analysi
discontinu equiti research coverag energi transfer partner
due acquisit energi transfer equiti
continu view revisions/earn neutral driver stock
market gener view earn backdrop thing
look great rear view mirror pretti big speed bump
road ahead primarili stronger us dollar ramp cost pressures/
erod margin expect noth weve heard first wave report
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
done anyth chang view anyth concern margin
damag sourc inflat ramp confirm fear
stronger dollar impact deepen
valuat tabl power price frac spread data rel price perform
ex-dividend date
highlight weekli ag note includ corn/soybean price declin
usda report soybean sale cancel non-gmo soybean
grown china eastern russia import china taiwan announc
import us soybean argentina soy plant area expect
y/i ag market commentari iowa farm survey indic average land valu
almost germani corn harvest estimate y/i french corn harvest
complet ukrain ytd grain harvest y/i usda lower russia grain prod est
updat loan flat week
weekli industri loan flat non-season adjust loan flat week-
over-week w/w basi end octob year-over-year
y/i basi follow trend
commerci industri w/w y/i
consum w/w y/i
commerci estat w/w y/i
residenti estat w/w y/i
equiti w/w y/i
w/w y/i
week octob
time earli result data point work
earn alreadi item make us want call time
tri understand what happen higher expect casualti loss ratio
us think loss cost trend might tri anticip
conserv estim smart underwrit
compani get conserv smart thought ahead curv
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
behind similarli travel weaker expect renew rate increas us
think price goe histori show arent mani
price head-fak slow rate increas like slow
revers also comment cat loss preannounc aig doozi
invest leverag invest incom take look invest
leverag found averag invest leverag ratio essenti
unchang vs time year ago also look roe invest
incom found two insur report invest incom
growth higher yield start final show invest
va guarante hedg cost continu declin look variabl
annuiti va guarante hedg cost trend recent va hedg cost
potenti implic variabl annuiti writer coverag includ
brighthous prudenti
result provid strong start earn
season reinforc strength underli med-tech fundament
simultan highlight challeng manag anoth round
dollar appreci
organ revenu growth like meet/exce high end guidanc
revenu guidanc increas expect ep guidanc
narrow revenu ep estim
ew expect in-lin quarter reiter revenu guidanc
high end rang ew forecast thv sale near high end
rang ep guidanc could narrow toward
upper half
readthrough jnj result gener posit
orthoped compani jnj result indic recon market trend stabl
sequenti posit lead indic
like rais organ revenu outlook expect reaffirm
guidanc cc revenu growth
midstream energi revisit mlp rise rate environ
inflat rise interest rate back convers revisit
analysi amz perform rise rate environ rel util
reit highlight four period past coupl year rate rose
rather quickli period rise interest rate yield-ori
stock mlp reit util gener outperform
investor like realloc capit high-p/e-multipl growth-ori
stock industri real asset
last seven day end friday alerian index amz
flat also flat amz ytd versu
median annual current yield midstream univers amz
yield roughli spread treasuri yield median
ev/ebitda median price/dcf midstream
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
highlight weekli mine note includ codelco submit eia
salvador copper mine china sep coal output highest africa mine
prod y/i aug vale anticip restart samarco iron ore mine anglo
american ramp mina rio delay year glencor cut job hail
coal mine anglo american said drill copper discoveri brazil
news nashvil
weekli perspect healthcar industri compani news valuat
sector price perform week end octob healthcar servic
stock outperform broader market health servic select
spsihp gain versu flat perform
institut pharmaci strongest-perform sub-
loss prior week manag gain versu declin
prior week weakest-perform sub-sector last week dialysi
week today earn mdso investor day await
week report earn go mdso investor day
listen cvs-aetna updat manag expect close
hpc discount supermarket aldi lidl continu pull away
tesco sainsburi latest figur reveal growth tradit
supermarket lag carrefour report lfl driven better
momentum franc strongli acceler growth brazil rapid
expans food e-commerc sale publici report organ revenu
exclud segment divestitur sonoco report revenu
driven higher volum particularli display packag
busi higher sell price implement recov rise freight
oper cost inflat omnicom report organ revenu
beverag report net incom exclud special item
nestl water report nine month end septemb organ growth
volum price crown hold report revenu
due impact signod acquisit increas beverag
volum pass-through higher materi cost double-digit increas
tinplat steel aluminum custom
tobacco british american tobacco lower guidanc full-year revenu
amid weaker perform japan product recal us bat said
expect revenu next-gener product includ e-cigarett
tobacco-h devic would come year
previou target industri volum us expect fall
year compani said full-year earn also lower owe
valu usd unless otherwis note
valu usd unless otherwis note
valu cad unless otherwis note
continu digest learn last week
wood product lumber spf creep lower syp
downward momentum acceler osb price extend
slide fall across region north central eastern canada
fell respect us south east
south west
paper packag pulp strong pulp market stay risi demand
grow annual capac add suggest market
condit continu tighten move forward provid hurrican
michael updat detail substanti damag westrock panama
citi mill suffer announc week mill linerboard product
ton/yr expect return full capac within day pulp side
product tons/yr project begin end novemb
compani expect reduc output level last month
top investor question week payment processor servic
quick summari question topic includ bank vs technolog payment
fraud consum sentiment retail innov global payment forecast
best worst perform stock week sq respect
thursday close thursday close
group trade higher w/w p/tsx
transport w/w cargojet w/w largest gainer
announc million bought deal offer senior debt downsid
bbd w/w stock-specif news weak share
w/w follow competitor downgrad cp share w/w trend
lower lead earn releas
automot diversifi industri w/w strength sector led
inc w/w off-set weak ecosynthetix w/
 automot supplier share week lnr mga mre
w/w respect modest strength
segment week except ipl plastic w/w follow neg
earn pre-announc competitor howev preview
canadian plastic packag sector releas week reiter
posit stanc iplp believ continu gener organ growth
industri peer
industri product w/w snc eif w/w
respect snc w/w primarili attribut stock
oversold respons announc compani
invit negoti remedi agreement feder govern
intern inc announc strong result ebitda
y/i exceed estim snc own
consid potenti sale stake
germani award solar auction wind auction
valu gbp unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
valu usd unless otherwis note
european commiss ask respons deviat eu rule italian
ifm consid polit risk insur uk renationalis
petrofac pfc award signific contract refineri project thailand
enquest enq result right issu gran tierra energi gte to/gt
pipelin explos presid ppc drill puesto flore field rio negro
highlight preview note auto supplier group ntm
yield hit histor buy signal group
group current ntm yield sold china concern
wltp emiss impact european product margin pressur
tariffs/raw materi grow us concern
oversold ye time buy preview highlight buy
dip indic green bottom sentiment valuat wed realli
feel comfort consensu number lower
specialti pharma focus week
event gx advair symphoni updat india gx week
focu gener sector high last week back earli read
nvs/sandoz india gener earli cross-read come week
specialti pharma earn start next week sever updat
watch per follow investor meet
southeast last week road week meet investor
discuss sector outlook
week ahead shop elli chkp
report result attend orcl openworld analyst day
data confer
last week attend analyst day host meet
manag sap report earn initi
coverag also announc chang presid
vrtx/pti nacfc day recap feedback pti doublet
valu usd unless otherwis note
valu usd unless otherwis note
attend nacf confer provid addit feedback weve
receiv physician vrtx detail triple-combo data present
poster present friday publish nejm well view
doc remain posit overal triple-combo efficaci safeti profil
highlight high enthusiasm expect
physician feedback also view pti data promis even acknowledg
small dataset limit broad interpret
earli preclin data gene-edit approach start emerg
remain interest potenti disrupt futur treatment modal
past week announc offer buy hifr
investor curiou anoth buyer may emerg given go-shop
period think unlik anoth buyer would come fold
point hifr asset seem natur fit oncor own
seem fair investor expect texa regulatori bodi
approv deal all-in-al believ high
probabl deal consumm
macro question persist among investor philadelphia util index
uti outperform basi point bp
quarter-to-d out-performance even greater
bp investor wonder whether late trade
defens postur might suggest recent popular util might
short-liv believ investor like keep focus
defens postur reach mid-term elect depend
outcom
adjust shufl among best play ad
list replac latter perform well late wherea former
ad ed defens play remov remov
hifr due oncor takeout ad nep
direct remain neutral small cap month view
watch page near term concern
potenti downsid russel crowd posit
continu unwind concern also broader us equiti
market month view think potenti risk reward
fairli balanc consid neutral driver scorecard
guid think current driver neutral russel
posit deal deploy neg
crowd problem us equiti includ small cap hasnt fix
yet watch page discuss last week
strategi spotlight market posit pickl macroscop think
extrem crowd us equiti one big reason market
turbul late inde us equiti futur posit total
contract return januari pre-financi crisi high earli
capit market busi name use certain branch subsidiari royal bank canada includ dominion secur inc
capit market llc europ limit royal bank canada hong kong branch royal bank canada sydney branch inform contain
report compil capit market sourc believ reliabl represent warranti express impli made royal
canada capit market affili person accuraci complet correct opinion estim contain
report constitut capit market judgement date report subject chang without notic provid good faith without
legal respons noth report constitut legal account tax advic individu tailor invest advic materi prepar gener
circul client prepar without regard individu financi circumst object person receiv invest
servic contain report may suitabl recommend consult independ invest advisor doubt
suitabl invest servic report offer sell solicit offer buy secur past perform guid
futur perform futur return guarante loss origin capit may occur capit market research analyst compens base
part overal profit capit market includ profit attribut invest bank revenu everi provinc canada state
 countri throughout world law regul type secur invest product may offer
resid well process result secur discuss report may elig sale jurisdict
capit market may restrict publish research report time time due regulatori restrict and/ intern complianc polici
case latest publish research report avail client may reflect recent materi chang applic industri and/or applic subject
compani capit market research report current date set forth research report report circumst
constru solicit act secur broker dealer jurisdict person compani legal permit carri
busi secur broker dealer jurisdict full extent permit law neither capit market affili
person accept liabil whatsoev direct consequenti loss aris use report inform contain herein matter
contain document may reproduc copi mean without prior consent capit market
addit inform avail request
public approv capit market llc member finra nyse sipc regist broker-deal accept
respons report dissemin unit state recipi report regist broker-deal bank act
broker dealer capac wish inform regard effect transact secur discuss report
contact place order capit market llc
public approv dominion secur inc member iiroc canadian recipi report design institut
ontario accredit investor british columbia alberta sophist purchas quebec similar permit purchas provinc
wish inform regard effect transact secur discuss report contact place order
dominion secur inc without way limit forego accept respons report dissemin canada
public approv europ limit el author prudenti regul author regul
conduct author fca prudenti regul author connect distribut unit kingdom materi gener
distribut unit kingdom retail client defin rule fca rbcel accept respons report dissemin
unit kingdom
materi distribut germani europ limit frankfurt branch regul bundesanstalt fr finanzdienstleistungsaufsicht bafin
receiv advic australia
materi distribut australia royal bank canada sydney branch abn afsl materi prepar
gener circul take account object financi situat need recipi accordingli recipi act
materi consid appropri materi regard object financi situat need materi relat acquisit
possibl acquisit particular financi product recipi australia obtain relev disclosur document prepar respect product
